Scimplify recently announced a $40 million Series B funding round to scale its revolutionary platform, which is transforming how specialty chemicals are developed, manufactured, and distributed worldwide. Accel and Bertelsmann co-led the round, which included participation from UMI and existing investors, including Omnivore and 3one4 Capital.
This latest funding round brings Scimplify’s total funding to $54 million, following $13.5 million raised across seed and Series A rounds. The investment will supercharge the company’s already impressive international growth, with exports currently reaching 16 countries and plans to aggressively expand geographically and into new industry segments.
The global chemical supply chain is being transformed. With fluctuating tariffs, trade wars, and growing geopolitical tensions, industries must scramble for new manufacturing solutions. And for specialty chemicals – the essential ingredients powering everything from pharmaceuticals to agriculture – this disruption is even more acute due to a fragmented and inflexible supply base.
Launched in mid-2023, Scimplify’s co-founders include Salil Srivastava, Sachin Santhosh, and Dheeraj Dhingra. These veterans spent the previous decade bringing Indian factories to a global customer base. Scimplify brings specialty chemical manufacturing under one roof. Their breakthrough approach: a full-stack solution that combines in-house scientific expertise with a massive network of over 200 specialized manufacturing plants across low-cost regions.
This creates a true ‘plug and play’ alternative to traditional manufacturing and customers simply bring their chemical needs. From there, Scimplify handles everything from R&D to specialized production, leveraging the perfect manufacturing partner for each specific chemistry without the capital investment or operational complexity of traditional approaches.
What separates Scimplify from traditional manufacturers is its speed and flexibility. While the company’s competitors remain anchored to fixed assets and limited chemistries, Scimplify can rapidly pivot across different chemical processes and scale production based on real-time customer needs. And their R&D capabilities provide expertise typically inaccessible to individual manufacturers, allowing them to solve complex chemical challenges that others simply cannot address.
Going forward, Scimplify plans to expand its international footprint aggressively while continually adding new industry segments through enhanced R&D capabilities. And the company is positioning itself at the center of a fundamental shift in global chemical manufacturing, building the infrastructure for a more resilient, innovative, and responsive industry.
KEY QUOTES:
“Global supply chains are shifting like never before. For decades, specialty chemical manufacturers have invested millions in facilities that can only produce a handful of compounds, often running at partial capacity while lacking R&D capabilities. This creates a paradox: excess capacity alongside supply shortages. We’ve flipped this model, connecting our scientific teams with hundreds of manufacturing plants to create a responsive ecosystem that can adapt as market needs shift.”
“Each specialty chemical requires significant scientific know-how and R&D investment. We’ve built a model that brings together the best scientific minds with hundreds of highly specialized manufacturing plants, creating a chemistry powerhouse that can tackle virtually any chemical challenge across critical industries.”
– Sachin Santhosh, Co-Founder at Scimplify
“The global supply chain for specialty chemicals is at an inflection point. Traditional manufacturing supply chains lack the flexibility required in today’s geopolitical environment as well as the rapid changes in end customer requirements. Scimplify is building an R&D led global manufacturing network which allows for flexibility coupled with innovation. At Accel, we have had a long standing thesis that R&D led speciality chemical companies which take advantage of the deep pool of manufacturing capabilities in India and globally can create global giants. We have been following the Scimplify journey from day 0 and their execution has been impressive. We look forward to this partnership and working with the team over the next decade.”
– Rachit Parekh, Principal at Accel
“We are excited to significantly double down on our commitment to Scimplify, after our initial investment last year. Their execution on the ground has been among the best we’ve seen, driving not just impressive topline growth but also a rapid multi-country export scale-up and the establishment of a cutting-edge R&D facility in Hyderabad. Scimplify is uniquely positioned to harness India’s strengths in specialty chemicals and capitalize on the evolving dynamics of global procurement in this sector.”
– Rohit Sood, Partner at Bertelsmann India Investments
